Celltrion Healthcare Co., Ltd.
KOE: 091990.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hyoung Ki Kim
- Employees
- 149
- Headquarters
- Incheon, South Korea
- IPO year
- 2017
- Market cap
- ₩10.7T
- Website
- https://www.celltrionhealthcare.com
Loading 091990…
Loading profile data…Frequently asked questions about 091990
What does Celltrion Healthcare Co., Ltd. (091990.KQ) do?
Celltrion Healthcare Co., Ltd. engages in the manufacture, processing, and sale of biosimilar and biological medicines to patients around the world. Its products include Remsima, a monoclonal antibody biosimilar that is used for rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, Crohn's disease in children,...
Where does 091990.KQ trade?
Celltrion Healthcare Co., Ltd. (091990.KQ) trades on the KOSDAQ.
What sector is 091990.KQ in?
Celltrion Healthcare Co., Ltd. (091990.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Celltrion Healthcare Co., Ltd.?
Hyoung Ki Kim is the chief executive officer of Celltrion Healthcare Co., Ltd. (091990.KQ).
Where is Celltrion Healthcare Co., Ltd. headquartered?
Celltrion Healthcare Co., Ltd. is headquartered in South Korea.
Does 091990.KQ pay a dividend?
Yes — Celltrion Healthcare Co., Ltd. (091990.KQ) paid a trailing twelve-month dividend of KRW 130.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 091990.KQ go public?
Celltrion Healthcare Co., Ltd. (091990.KQ) completed its initial public offering in 2017.